Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01208311 · ClinicalTrials.gov registry record
Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound
A clinical trial of Hepatitis C and Alcoholism, sponsored by Northwell Health.
- Completed
- Registry status
- 7
- Enrollment target
- 1
- Study location
NCT01208311 is a study of Hepatitis C and Alcoholism that has completed, run by Northwell Health. The registered enrollment target is 7 participants, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01208311, a study of Hepatitis C and Alcoholism, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the amount of fibrosis in the liver of hepatitis C patients with advanced fibrosis, using endoscopic ultrasound.
Conditions Studied
Study Locations (1)
New York
- LIJ Medical Center- NSLIJ Health System - New Hyde Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2004-12 |
| Est. Completion | 2016-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01208311
The ClinicalTrials.gov registry entry for NCT01208311 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (100% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Hepatitis C appearing as the primary indexed condition, and to 0 interventions.
NCT01208311 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01208311 about?
NCT01208311 is a clinical study titled "Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound". The purpose of this study is to determine the amount of fibrosis in the liver of hepatitis C patients with advanced fibrosis, using endoscopic ultrasound.
What is the current status of trial NCT01208311?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2004-12. Estimated completion is 2016-12.
What conditions does trial NCT01208311 study?
This clinical trial studies the following conditions: Hepatitis C, Alcoholism, Cirrhosis.
Who is sponsoring clinical trial NCT01208311?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01208311 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
Evaluation of Patients With Liver Disease
RECRUITING
-
The HOPE Study: Characterizing Patients With Hepatitis B and C
RECRUITING
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.